Search

Search Constraints

You searched for: Author/Creator Pecorelli, S.

Search Results

1. 00086 ANALYSIS OF GENE EXPRESSION PATTERNS THAT DEFINES SEROUS PAPILLARY OVARIAN CARCINOMAS. (1st September 2005)

2. 00099 THE SURVIVAL BENEFIT OF INTERVAL DEBULKING SURGERY (IDS) IN ADVANCED OVARIAN CANCER IS MAINTAINED DURING TEN YEARS; THE EORTC GCG 55865 STUDY. (1st September 2005)

3. 0009: Extending the Platinum-Free Interval (PFI) with a Non-Platinum Therapy in Platinum (P)-Sensitive Recurrent Ovarian Cancer (Oc): Results From the Socrates Retrospective Study. (1st October 2006)

4. 0047: Claudin-3 and Claudin-4 Receptor Overexpression: Novel Targets for a Type Specific Therapy Against Uterine Serous Papillary Carcinomas Using Clostridium Perfringens Enterotoxin. (1st October 2006)

5. 0348: Phase I Dose Escalation Trial of Hpv16/18 E7-Pulsed Dendritic Cell Vaccination in Stage Ib-Iia Cervical Cancer Patients. (1st October 2006)

9. FIRST RESULTS OF A RANDOMISED TRIAL COMPARING RADIOTHERAPY VERSUS- OBSERVATION POST OPERATIVELY IN PATIENTS WITH UTERINE SARCOMAS. AN EORTC-GCG STUDY. Issue 1 (1st March 2003)

10. Long-term follow-up confirms a survival advantage of the paclitaxel–cisplatin regimen over the cyclophosphamide–cisplatin combination in advanced ovarian cancer. (1st October 2003)